PharmaCyte Biotech, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 8/30/2016
Contact Info
  • 23046 Avenida de la Carlota
  • Suite 600
  • Laguna Hills, CA 92653

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Oct 31, 2016 10-Q
CIK 0001157075
Fiscal Year End 4/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 1996
Employees 6 a/o Feb 25, 2016
Company Officers/Contacts
Kenneth L. Waggoner CEO, President, General Counsel
Gerald W. Crabtree, Ph.D. COO
Company Directors
Kenneth L. Waggoner Chairman
Thomas Liquard
Gerald W. Crabtree, Ph.D.
Company Notes
  • Formerly=Nuvilex, Inc. until 1-2015
  •, Inc. until 3-2009
Service Providers
Accounting/Auditing Firm
Armanino LLP
12657 Alcosta Blvd
Suite 500
San Ramon, CA, 94583
United States

Legal Counsel
Pepper Hamilton LLP
3000 Two Logan Square
Eighteenth and Arch Streets
Philadelphia, PA, 19103-2799
United States

Investor Relations Firm
Stonegate Capital, Inc.
8201 Preston Rd.
Suite 325
Dallas, TX, 75225
United States

PMCB Security Details
Share Structure
Market Value1 $59,593,107 a/o Dec 02, 2016
Authorized Shares 1,490,000,000 a/o Aug 29, 2016
Outstanding Shares 848,904,665 a/o Aug 29, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 817,204,665 a/o Aug 29, 2016
Par Value 0.0001
Shareholders of Record 1,317 a/o Aug 29, 2016
Short Selling Data
Short Interest 35,363 (-77.58%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security